Memorial symptom assessment scale Journal Article


Authors: Chang, V. T.; Hwang, S. S.; Thaler, H. T.; Kasimis, B. S.; Portenoy, R. K.
Article Title: Memorial symptom assessment scale
Abstract: Patients with advanced illnesses often have multiple symptoms. As interest in palliative care and interventions for symptom control increase, the ability to assess multiple symptoms has become more important. A number of instruments have been developed to meet this need in cancer patients. This article reviews the development and applications of a multidimensional instrument, the Memorial Symptom Assessment Scale. The Memorial Symptom Assessment Scale has 32 symptoms and three dimensions of frequency, severity, and distress. Shorter versions - The Memorial Symptom Assessment Scale Short Form (32 symptoms with one dimension) and the Condensed Memorial Symptom Assessment Scale (14 symptoms with one dimension), and a version for children aged 7-12 years, have also been developed. A distinctive feature is the summary subscales for physical distress, psychological distress, and The Global Distress Index. The Memorial Symptom Assessment Scale has proven useful in description of symptom epidemiology, the role of symptoms in pain, fatigue, and spirituality; as a predictor of survival, and in proxy assessments of pain. The Memorial Symptom Assessment Scale has been used in studies of cancer and AIDS patients, and patients with advanced medical illnesses. Possible future roles of instruments such as the Memorial Symptom Assessment Scale include use in clinical trials, for pharmacoeconomic analyses, definition of symptom clusters and symptom burden, the development of symptom outcome measures, symptom monitoring, and improving care for patients. Continued research is needed for the versions of the Memorial Symptom Assessment Scale and other symptom instruments in different populations and applications. © Future Drugs Ltd. All rights reserved.
Keywords: survival; cancer survival; fatigue; review; advanced cancer; paclitaxel; cancer patient; cancer palliative therapy; quality of life; pain; patient monitoring; prediction; medical assessment; age; health care quality; medical instrumentation; patient care; symptom; disease severity; clinical study; distress syndrome; outcomes research; rating scale; acquired immune deficiency syndrome; symptomatology; antiretrovirus agent; highly active antiretroviral therapy; taxane derivative; morphine; recombinant granulocyte colony stimulating factor; pain assessment; religion; fentanyl; proxy; physical disease; human; memorial symptom assessment scale
Journal Title: Expert Review of Pharmacoeconomics and Outcomes Research
Volume: 4
Issue: 2
ISSN: 1473-7167
Publisher: Informa Healthcare  
Date Published: 2004-04-01
Start Page: 171
End Page: 178
Language: English
DOI: 10.1586/14737167.4.2.171
PROVIDER: scopus
DOI/URL:
Notes: Expert Rev. Pharmacoecon. Outcomes Res. -- Cited By (since 1996):11 -- Export Date: 16 June 2014 -- CODEN: ERPOB -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Howard T Thaler
    245 Thaler